stockrowGilead Sciences, Inc. (GILD) vs Pfizer Inc. (PFE)
- Gilead Sciences, Inc. GILD 168.15 +0.35%
- Pfizer Inc. PFE 29.31 −0.48%
Gilead Sciences, Inc. and Pfizer Inc. are both Drug Manufacturers General companies. Gilead Sciences, Inc. is the larger, with a market value of $207.8B against $170.3B — 1.2× the size. Gilead Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Pfizer Inc. trades at 42.2×. Gilead Sciences, Inc. grew revenue faster over the last twelve months: 6.54% against 1.34%. Pfizer Inc. has the higher net margin (6.34% vs −12.5%) and the higher return on invested capital (6.19% vs −4.51%). Both pay a dividend; Pfizer Inc. yields more (7.18% vs 1.94%). Across the 22 metrics below, Pfizer Inc. leads on 14 and Gilead Sciences, Inc. on 8.
Valuation
Profitability
| Metric | GILD | PFE | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 79.93% | 73.38% | 73.01% |
| Operating margin | (7.63%) | 21.44% | 18.34% |
| Net margin | (12.47%) | 6.34% | 7.31% |
| Free cash flow margin | 44.47% | 18.52% | 18.52% |
| Return on equity | (22.45%) | 4.42% | 5.80% |
| Return on assets | (7.03%) | 1.95% | 2.28% |
| Return on invested capital | (4.51%) | 6.19% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack